Treventis attended the BIO International Convention that took place on June 3-6 in Philadelphia, Pennsylvania, with more than 16,000 attendees passionate about creating new opportunities to partner and collaborate on innovative drug projects aimed at improving the lives of patients.
This year, Treventis was a “Buzz of BIO” competition finalist and was invited to speak in recognition of this honor. CEO Christopher Barden presented a talk on the company, presenting an overview of the company’s technology and programs in protein misfolding disease therapeutics.